Recalls & Warnings December 08, 2017 Limbrel Capsules for Osteoarthritis Linked With Potentially Life-Threatening Health Risk, FDA Warns On December 4, 2017, the FDA urged consumers not to take Limbrel (Primus Pharmaceuticals), a capsule marketed to manage the metabolic processes associated with osteoarthritis, because it has been associated with serious adverse events, including drug-induced liver injury and a lung
(Price revision effective from May 13, 2025) Isotretinoin (Aknetrent) Pricing Monthly Cost (Including Consultation & Tests) Isotretinoin treatment is recommended to be continued for a standard 6-month period with monthly consultations and tests, based on international guidelines
Limit temperature cycling
Niklison Chirou Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made